Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form
LAVAL, Quebec, Jan. 12, 2018 /PRNewswire/ -- Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ( " Valeant " ) , today announced that the U.S. Food and Drug Administration (FDA) has accepted the New...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news
More News: Acne | Dermatology | Drugs & Pharmacology | Food and Drug Administration (FDA) | New Drug Applications | Skin